- Country: Chile
- Summary: Buying of Budesonida Formoterol Medicine by Ministerial Program
- CLT Ref No: 119313825
- Deadline: 22 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 1978-34-LE25
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- These bidding bases are intendedBudesonide/ formoterol incorporated into the PM program, IRA was: Ges 61, bronchial asthma in people 15 years and over. The specific description of the requirements of the products and/ or services that are tendered in this process is detailed in the technical specifications form and the offer must bestick to the descriptions and specifications indicated. The mere fact of participating in this tender implies the acceptance of all the conditions established in these bases.
Products or services:Budesonida - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINBuying of Budesonida Formoterol Medicine by Ministerial Program - Chile Tender
The MAULE HEALTH SERVICE, a Government sector organization in Chile, has announced a new tender for Buying of Budesonida Formoterol Medicine by Ministerial Program. This tender is published on ChileTenders under CLT Ref No: 119313825 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-22.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
